VersaPeutics

Executive Summary

VersaPeutics is a San Diego-based private biotech startup founded in 2016, dedicated to developing small-molecule therapies for major nervous system disorders, including Alzheimer’s disease, spinal cord injury, and neuropathic pain. The company is in its early stages, actively building a team of scientists and business professionals to advance its pipeline. While specific financial details, valuation, and clinical stage are not publicly disclosed, VersaPeutics leverages its location in a prominent biotech hub to attract talent and potential partners. The company’s focus on high-need areas with limited treatment options presents a significant opportunity, though it operates in a competitive landscape with high technical risk.

Upcoming Catalysts (preview)

• TBDLead Optimization and Preclinical Candidate Nomination for Alzheimer’s Program30% success
• TBDSeries A Financing or Grant Award to Fund IND-Enabling Studies40% success
• TBDResearch Partnership or Licensing Deal for Spinal Cord Injury Asset25% success